Page last updated: 2024-10-26

dipivefrin and Capsule Opacification

dipivefrin has been researched along with Capsule Opacification in 1 studies

dipivefrin: used in treatment of both primary & open angle glaucoma; RN given refers to (+-)-isomer
dipivefrin : The dipivalate ester of (+-)-epinephrine (racepinephrine). A pro-drug of epinephrine, the hydrochloride is used topically as eye drops to reduce intra-ocular pressure in the treatment of open-angle glaucoma or ocular hypertension.

Capsule Opacification: Clouding or loss of transparency of the posterior lens capsule, usually following CATARACT extraction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Auffarth, GU1
Brézin, A1
Lignereux, F1
Khoramnia, R1
Yildirim, TM1
Kohnen, T1
Bianco, J1

Trials

1 trial available for dipivefrin and Capsule Opacification

ArticleYear
Randomized multicenter trial to assess posterior capsule opacification and glistenings in two hydrophobic acrylic intraocular lenses.
    Scientific reports, 2023, 02-17, Volume: 13, Issue:1

    Topics: Capsule Opacification; Cataract Extraction; Humans; Lens, Crystalline; Lenses, Intraocular; Prospect

2023